Caspofungin labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
{{Caspofungin}}
{{Caspofungin}}
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


{|
{|
|[[File:Cancidaspackage.JPG|600px|thumb]]]
|[[File:Cancidaspackage.JPG|600px|thumb]]
|}
|}


{|
{|
|File:Cancidaspackage2.JPG|600px|thumb]]
|[[File:Cancidaspackage2.JPG|600px|thumb]]
|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c | publisher =  | date =  | accessdate =  }}</ref>
|}
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Latest revision as of 04:01, 5 January 2014

Caspofungin
CANCIDAS® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]



[1]

References

  1. "CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.]".

Adapted from the FDA Package Insert.